110 related articles for article (PubMed ID: 6777800)
1. CSF GABA in psychotic disorders.
Bowers MB; Gold BI; Roth RH
Psychopharmacology (Berl); 1980; 70(3):279-82. PubMed ID: 6777800
[TBL] [Abstract][Full Text] [Related]
2. Average evoked responses (AER) and homovanillic acid (HVA) in cerebrospinal fluid (CSF) in a psychotic patient with Addison's disease.
Mattsson B; Perris C
Arch Psychiatr Nervenkr (1970); 1974; 219(4):351-5. PubMed ID: 4447456
[No Abstract] [Full Text] [Related]
3. Clinical processes and central dopaminergic activity in psychotic disorders.
Bowers MB; Heninger GR; Sternberg D; Meltzer HY
Commun Psychopharmacol; 1980; 4(3):177-83. PubMed ID: 6112093
[No Abstract] [Full Text] [Related]
4. GABA levels in CSF of patients with psychiatric disorders.
Gold BI; Bowers MB; Roth RH; Sweeney DW
Am J Psychiatry; 1980 Mar; 137(3):362-4. PubMed ID: 7356067
[TBL] [Abstract][Full Text] [Related]
5. Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients.
Garver DL; Bissette G; Yao JK; Nemeroff CB
Am J Psychiatry; 1991 Apr; 148(4):484-8. PubMed ID: 2006695
[TBL] [Abstract][Full Text] [Related]
6. High doses of haloperidol in schizophrenia. A clinical, biochemical, and pharmacokinetic study.
Zarifian E; Scatton B; Bianchetti G; Cuche H; Loo H; Morselli PL
Arch Gen Psychiatry; 1982 Feb; 39(2):212-5. PubMed ID: 7065833
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid homovanillic acid is correlated to psychotic features in neurological patients with delirium.
Ramirez-Bermudez J; Ruiz-Chow A; Perez-Neri I; Soto-Hernandez JL; Flores-Hernandez R; Nente F; Montes S; Rios C
Gen Hosp Psychiatry; 2008; 30(4):337-43. PubMed ID: 18585537
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid homovanillic acid patterns during neuroleptic treatment.
Bowers MB; Heninger GR
Psychiatry Res; 1981 Jun; 4(3):285-90. PubMed ID: 6115436
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders.
Kasa K; Otsuki S; Yamamoto M; Sato M; Kuroda H; Ogawa N
Biol Psychiatry; 1982 Aug; 17(8):877-83. PubMed ID: 7115838
[TBL] [Abstract][Full Text] [Related]
10. Relationship between estimated premorbid adjustment and CSF homovanillic acid and 5-hydroxyindoleacetic acid levels.
Leckman JF; Bowers MB; Sturges JS
Am J Psychiatry; 1981 Apr; 138(4):472-7. PubMed ID: 6163366
[TBL] [Abstract][Full Text] [Related]
11. Gamma-aminobutyric acid and homovanillic acid concentration in the CSF of patients with senile dementia of Alzheimer's type.
Zimmer R; Teelken AW; Trieling WB; Weber W; Weihmayr T; Lauter H
Arch Neurol; 1984 Jun; 41(6):602-4. PubMed ID: 6721733
[TBL] [Abstract][Full Text] [Related]
12. CSF acid monoamine metabolites in psychotic syndromes: what might they signify?
Bowers MB
Biol Psychiatry; 1978 Jun; 13(3):375-83. PubMed ID: 667235
[TBL] [Abstract][Full Text] [Related]
13. [Use of haloperidol in high doses in schizophrenia. Clinical, biochemical and pharmacokinetic study].
Scatton B; Zarifian E; Bianchetti G; Cuche H; Loo H; Morselli PL
Encephale; 1982; 8(1):1-8. PubMed ID: 7094868
[TBL] [Abstract][Full Text] [Related]
14. Serotonin (5HT) systems in psychotic states.
Bowers MB
Psychopharmacol Commun; 1975; 1(6):655-62. PubMed ID: 1224018
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid probenecid studies: a reinterpretation.
Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
[TBL] [Abstract][Full Text] [Related]
16. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.
Kahn RS; Davidson M; Knott P; Stern RG; Apter S; Davis KL
Arch Gen Psychiatry; 1993 Aug; 50(8):599-605. PubMed ID: 7688208
[TBL] [Abstract][Full Text] [Related]
17. [Gamma-aminobutyric acid (GABA) and homovanillic acid (HVA) levels in the cerebrospinal fluid of patients with epilepsy].
Klimowicz-Młodzik I; Pisarski W; Sasinowska M; Smiałek M
Neuropatol Pol; 1985; 23(3):419-32. PubMed ID: 4088467
[No Abstract] [Full Text] [Related]
18. CSF levels of gamma-aminobutyric acid in schizophrenia. Low values in recently ill patients.
van Kammen DP; Sternberg DE; Hare TA; Waters RN; Bunney WE
Arch Gen Psychiatry; 1982 Jan; 39(1):91-7. PubMed ID: 7055411
[TBL] [Abstract][Full Text] [Related]
19. [Homovanillic acid (HVA) and gamma-aminobutyric acid (GABA) levels in the cerebrospinal fluid of patients with extrapyramidal syndromes].
Smiałek M; Królikiewicz-Sciborowska H; Skrobisz MD; Niemczewska-Syropolska M; Sasinowska M
Neuropatol Pol; 1986; 24(4):585-602. PubMed ID: 3587659
[No Abstract] [Full Text] [Related]
20. Plasma catecholamine metabolites and treatment response at neuroleptic steady state.
Bowers MB; Swigar ME; Jatlow PI; Hoffman FJ
Biol Psychiatry; 1989 Mar; 25(6):734-8. PubMed ID: 2923935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
